Alebund Pharmaceutical announced the 1st closing of RMB 550 million in Series C financing
Press Releases
Alebund Pharmaceuticals  
January 7, 2025

Alebund Pharmaceutical announced the 1st closing of RMB 550 million in Series C financing

SHANGHAI and YANGZHOU, China, Jan. 7, 2025 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for renal diseases and related chronic

avatar profile Olean Times Herald

Olean Times Herald


Local & Social